Breaking News

Asahi Kasei to Acquire Bionova Scientific

Biologics CDMO will complement Asahi Kasei’s bioprocess consumables and equipment and biosafety testing services business.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Bionova Scientific, a biologics contract development and manufacturing organization (CDMO) specializing in the development and manufacture of recombinant protein therapeutics, reached an agreement to be acquired by the U.S. arm of Asahi Kasei Medical, a core operating company of the Asahi Kasei Group. The acquisition represents a strategic complementary addition to Asahi Kasei Medical’s bioprocess business, which is renowned for Planova virus removal filters, MOTIV inline buffer formulation syst...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters